Filing Details
- Accession Number:
- 0001225208-18-005098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-02 15:24:49
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-02 15:24:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1508517 | H Charles Hill | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-28 | 101,872 | $27.37 | 207,942 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-28 | 1,100 | $36.84 | 206,842 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 3,200 | $36.85 | 203,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 5,400 | $36.82 | 198,242 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 17,079 | $36.83 | 181,163 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 19,606 | $36.31 | 161,557 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-02-28 | 61,836 | $35.70 | 99,721 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 101,872 | $0.00 | 101,872 | $27.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-28 | 2018-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 11,414 | Indirect | By Rule 16b-3 Plan |
Footnotes
- The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
- The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Billionaire Hedge Funds
